Sentences with phrase «woman with ovarian cancer»
By the time of diagnosis the majority of women with ovarian cancer already have extensive spread of the disease which makes it difficult to treat by surgery or chemotherapy.
sciencedaily.com
For a young woman with ovarian cancer, the options can be grim.
The investigators discovered that women with ovarian cancer linked to genes inherited from their father's mother developed the cancer much earlier than those with ovarian cancer linked to genes from their mother.
Previous research had shown that sisters of women with ovarian cancer have a higher risk for the disease than their mother, but the reasons for this were unclear.
In their research, scientists at Rutgers created animal models that closely resemble the cancerous tumors found in women with ovarian cancer by injecting tumor tissues obtained from gynecological cancer patients treated at the Cancer Institute into laboratory mice.
Nearly 20 percent of women with ovarian cancer do not undergo surgery, despite it being a standard part of treatment recommendations, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
A new screening method can detect twice as many women with ovarian cancer as conventional strategies, according to the latest results from the largest trial of its kind led by UCL.
«What we've discovered will help clinicians to better treat women with ovarian cancer,» says Dr. Ben Tsang, senior scientist at the Ottawa Hospital Research Institute and professor at the University of Ottawa.
To define the impact of an inventory of TILs on antitumor immunity, researchers analyzed 198 blood samples from 99 women with ovarian cancer using the ImmunoSEQ platform.
The results of these two additional trials are expected within a year and will hopefully add to a successful FDA application for approval making this agent available to American women with ovarian cancer.
An analysis of mutations in the BRCA1 and BRCA2 genes reveals that women with breast cancer and women with ovarian cancer harbored mutations in different regions of the genes.
«Women with ovarian cancer gain extra months with addition of drug to standard chemotherapy.»
This holistic approach is revealed in many ways, from helping a young woman with ovarian cancer fulfill her dream of becoming a mother, to helping a chef with tongue cancer preserve his sense of taste.
Guard against ovarian woes When Australian researchers recently compared women with ovarian cancer to cancer - free women, they found that roughly one glass of wine a day seemed to reduce the risk of the disease by as much as 50 percent.
However, many women with ovarian cancer disagree.
It is now in a phase II clinical trial in women with ovarian cancer, which almost always has p53 mutations.
Olaparib was licensed in December for women with ovarian cancer and inherited BRCA mutations, but the new research suggests it could also benefit men with genomic faults within their tumours.
PHILADELPHIA, PA — Nearly 20 percent of women with ovarian cancer do not undergo surgery, despite it being a standard part of treatment recommendations, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
«We wanted to study whether this was also true in cancer patients, and whether it occurred with the chemotherapy used to treat women with ovarian cancer,» Balkwill added.
She estimates that about 50 percent of women with ovarian cancer have tumors with this type of tumor and would qualify for the trial, which needs about $ 2 million in philanthropic funding before it could begin.
«New screening technique could pick up twice as many women with ovarian cancer.»
In order to assess whether an improved diet could reduce the risk of ovarian cancer in African - American women, Qin analyzed the diets of 415 women with ovarian cancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United States.
A blood test for CA - 125, a protein that is elevated in some women with ovarian cancer, is frequently used to monitor tumor recurrence, but the test lacks sufficient accuracy for screening purposes.
They work to block chemotherapy, which is why nearly every woman with ovarian cancer becomes resistant to treatment.
«This study provided encouraging preliminary results for the use of RT in women with ovarian cancer.»
And with an additional finding that women with ovarian cancer have a different bacterial makeup, researchers are asking whether these tiny organisms could play a role in cancer development or progression.
«Bacteria found in female upper reproductive tract, once thought sterile: Researchers also uncover a trend toward a distinct bacterial profile in women with ovarian cancer.»
Keku said the bacterial strains in the women with ovarian cancer were more pathogenic.
«This is a tremendous discovery and could mean the difference between life or death for some women with ovarian cancer,» says Maureen G. Phipps, MD, MPH, chief of obstetrics and gynecology at Women & Infants.
«This would be an individualized treatment that could increase survival rates of some women with ovarian cancer.»
«One in five women with ovarian cancer does not undergo surgery, study reveals: Results show survival benefit of surgery for patients regardless of age or advanced disease, and point to barriers to cancer care delivery.»
When the researchers used the new approach blindly to test a group of 106 healthy women and 100 women with ovarian cancer, they found that the test correctly diagnosed cancer victims 95 percent of the time.
For women with ovarian cancer, a particularly deadly form of gynecologic cancer, even improvements in treatment outcomes have been elusive.
This approach has the potential to provide a novel immunotherapy for women with ovarian cancer.
A new study conservatively estimates that one in five women with ovarian cancer has inherited genetic mutations that increase the risk of the disease, according to research by the School of Medicine's Li Ding, PhD, and her colleagues.
Just 20 % of women with ovarian cancer are cured — meaning the illness never comes back — after undergoing surgery and chemo.